Weekly Trading Update

Weekend Paper Roundup 21/12/2015



Financial Times
-Withdrawals storm batters US corporate bond market
- JPMorgan fined $307 million for misleading advice
- Blow for Shell’s van Beurden as some lose faith in BG marriage
- Aveva stock slides as time takes toll on Schneider deal
- Rolls-Royce restructure begins under gaze of MoD

The Wall Street Journal
- VW pares executive layers
- Greek’s port privatisation advances
- AstraZeneca to take stake in biotech Acerta
- Samsung bets big on drug making
- Drug executive Martin Shkreli arrested in US

The Guardian
- Netflix paid no corporation tax despite 4.5 million UK subscribers, report claims
- Warm December gives nervous UK retailers the Christmas shivers
- Brazil dam disaster: judge freezes assets of miners BHP and Vale
- Sports Direct boss Mike Ashley faces Findel board defeat
- UK buyers need to save up for 24 years to get on housing ladder

The Telegraph
- Bank of England hawk Martin Weale signals rate rises further away
- Oil crashes to 11-year low sending chills through equity market
- Randgold Resources pulls out of Ghana gold mine joint venture
- BG investor sells £100 million of shares
- Treasury hires RBS and Barclays to run state bank accounts

The Times
- Shire lures US rival with £8 billion cash promise
- Post Office strikes bank deal
- BHP Billiton prepares to slash £4 billion dividend
- Whitehall trade bosses ordered to reapply for jobs
- Yahoo activist woos founders

Daily Mail
- NBCUniversal eyes £11 billion bid for ITV
- Merger of AA and Saga fuels £1.7 billion payout for Charterhouse, Permira and CVC
- Jump in sales fuels hopes for higher growth figures in last quarter
- Damning report reveals ministers were deaf to ‘warning bells sound by UK steel industry’
- Compass chief executive’s pay soars to £1 million while his bonus escalates by 8%

The Independent
- Toshiba to cut 7000 jobs as it predicts a record $4.5 billion loss
- Apprenticeship levy will hit jobs, warns CBI chief
- Firms on collision course with pensions regulator over auto-enrolment
- GlaxoSmithKline spends $19 billion on US rival’s drugs to boost HIV battle
- Flood plan has ‘failed to protect the poorest’


DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.